Symbols / CLYM Stock Climb Bio, Inc.

Healthcare • Biotechnology • United States • NGM
CLYM (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index —
Sector Healthcare
Industry Biotechnology
CEO —
Exch · Country NGM · United States
Market Cap 424.18M
Enterprise Value —
Income —
Sales —
FCF (ttm) —
Book/sh —
Cash/sh —
Employees —
Insider 10d —
IPO —
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout —
P/E —
Forward P/E —
PEG —
P/S —
P/B —
P/C —
EV/EBITDA —
EV/Sales —
Quick Ratio —
Current Ratio —
Debt/Eq —
LT Debt/Eq —
EPS (ttm) —
EPS next Y —
EPS Growth —
Revenue Growth —
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) —
Earnings (prior) —
ROA —
ROE —
ROIC —
Gross Margin —
Oper. Margin —
Profit Margin —
Shs Outstand —
Shs Float —
Insider Own —
Instit Own —
Short Float —
Short Ratio —
Short Interest —
52W High —
vs 52W High —
52W Low —
vs 52W Low —
Beta —
Impl. Vol. —
Rel Volume —
Avg Volume —
Volume —
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom —
Prev Close —
Price —
Change —
About

No company description available for this symbol.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
Current target
—
Low
—
High
—
Mean
—
News
RSS: Latest CLYM news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.00
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
0.00
Operating Expense
67.88
+123.59%
30.36
-24.62%
40.27
-10.77%
45.13
Research And Development
46.71
+225.84%
14.34
-6.98%
15.41
-41.21%
26.21
Selling General And Administration
21.17
+32.11%
16.02
-35.55%
24.86
+31.41%
18.92
General And Administrative Expense
21.17
+32.11%
16.02
-35.55%
24.86
+31.41%
18.92
Other Gand A
21.17
+32.11%
16.02
-35.55%
24.86
+31.41%
18.92
Other Operating Expenses
—
—
—
—
Total Expenses
67.88
+123.59%
30.36
-24.62%
40.27
-10.77%
45.13
Operating Income
-67.88
-123.59%
-30.36
+24.62%
-40.27
+10.77%
-45.13
Total Operating Income As Reported
-67.88
+17.24%
-82.02
-103.65%
-40.27
+10.77%
-45.13
EBITDA
-67.79
-123.27%
-30.36
+24.62%
-40.27
+10.77%
-45.13
Normalized EBITDA
-67.50
-416.77%
21.31
+152.21%
-40.81
+6.51%
-43.65
Reconciled Depreciation
0.10
0.00
—
—
EBIT
-67.88
-123.59%
-30.36
+24.62%
-40.27
+10.77%
-45.13
Total Unusual Items
-0.29
+99.44%
-51.67
-9739.55%
0.54
+136.12%
-1.48
Total Unusual Items Excluding Goodwill
-0.29
+99.44%
-51.67
-9739.55%
0.54
+136.12%
-1.48
Special Income Charges
0.00
+100.00%
-51.66
0.00
—
Other Special Charges
—
51.66
—
—
Net Income
-59.85
+19.01%
-73.90
-110.42%
-35.12
+22.38%
-45.24
Pretax Income
-59.85
+19.01%
-73.90
-110.42%
-35.12
+22.38%
-45.24
Net Non Operating Interest Income Expense
8.32
+2.35%
8.13
+76.02%
4.62
+236.00%
1.38
Net Interest Income
8.32
+2.35%
8.13
+76.02%
4.62
+236.00%
1.38
Interest Income Non Operating
8.32
+2.35%
8.13
+76.02%
4.62
+236.00%
1.38
Interest Income
8.32
+2.35%
8.13
+76.02%
4.62
+236.00%
1.38
Other Income Expense
-0.29
+99.44%
-51.67
-9739.55%
0.54
+136.12%
-1.48
Other Non Operating Income Expenses
—
—
—
1.38
Gain On Sale Of Security
-0.29
-3133.33%
-0.01
-101.68%
0.54
+136.12%
-1.48
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-59.85
+19.01%
-73.90
-110.42%
-35.12
+22.38%
-45.24
Net Income From Continuing Operation Net Minority Interest
-59.85
+19.01%
-73.90
-110.42%
-35.12
+22.38%
-45.24
Net Income From Continuing And Discontinued Operation
-59.85
+19.01%
-73.90
-110.42%
-35.12
+22.38%
-45.24
Net Income Continuous Operations
-59.85
+19.01%
-73.90
-110.42%
-35.12
+22.38%
-45.24
Normalized Income
-59.56
-167.94%
-22.23
+37.66%
-35.66
+18.52%
-43.76
Net Income Common Stockholders
-59.85
+19.01%
-73.90
-110.42%
-35.12
+22.38%
-45.24
Otherunder Preferred Stock Dividend
—
—
—
0.00
Diluted EPS
-0.88
+42.48%
-1.53
-17.69%
-1.30
+24.42%
-1.72
Basic EPS
-0.88
+42.48%
-1.53
-17.69%
-1.30
+24.42%
-1.72
Basic Average Shares
47.77
-1.10%
48.30
+78.97%
26.99
+2.57%
26.31
Diluted Average Shares
47.77
-1.10%
48.30
+78.97%
26.99
+2.57%
26.31
Diluted NI Availto Com Stockholders
-59.85
+19.01%
-73.90
-110.42%
-35.12
+22.38%
-45.24
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
167.74
-22.77%
217.19
+96.60%
110.47
-18.17%
134.99
Current Assets
105.85
-31.65%
154.87
+40.47%
110.25
-17.96%
134.39
Cash Cash Equivalents And Short Term Investments
101.08
-33.02%
150.92
+41.31%
106.80
-13.57%
123.57
Cash And Cash Equivalents
35.69
-59.09%
87.23
-6.32%
93.11
+113.63%
43.59
Cash Equivalents
35.69
-59.09%
87.23
-6.32%
93.11
+113.63%
43.59
Cash Financial
—
—
—
—
Other Short Term Investments
65.39
+2.68%
63.69
+365.37%
13.69
-82.89%
79.98
Receivables
—
1.12
-54.59%
2.46
-62.05%
6.49
Taxes Receivable
—
0.00
-100.00%
2.02
-68.82%
6.49
Accrued Interest Receivable
—
1.12
+154.32%
0.44
—
Prepaid Assets
4.77
+20.64%
3.95
+348.69%
0.88
-33.76%
1.33
Other Current Assets
—
0.26
+128.57%
0.11
-96.27%
3.00
Total Non Current Assets
61.90
-0.67%
62.31
+29019.16%
0.21
-64.27%
0.60
Net PPE
0.79
+15.09%
0.69
+246.23%
0.20
-57.75%
0.47
Gross PPE
0.79
+15.09%
0.69
+246.23%
0.20
-57.75%
0.47
Other Properties
0.79
+15.09%
0.69
+246.23%
0.20
-57.75%
0.47
Investments And Advances
59.57
-3.31%
61.61
0.00
0.00
Other Non Current Assets
1.53
+9462.50%
0.02
+6.67%
0.01
-88.28%
0.13
Total Liabilities Net Minority Interest
7.27
+37.00%
5.31
+84.88%
2.87
-54.28%
6.28
Current Liabilities
6.98
+41.63%
4.93
+74.06%
2.83
-53.53%
6.10
Payables And Accrued Expenses
6.67
+42.35%
4.68
+98.43%
2.36
-59.27%
5.80
Payables
2.27
+221.84%
0.70
+968.18%
0.07
-91.20%
0.75
Accounts Payable
2.27
+221.84%
0.70
+968.18%
0.07
-91.20%
0.75
Current Accrued Expenses
4.40
+10.55%
3.98
+73.42%
2.29
-54.53%
5.05
Current Debt And Capital Lease Obligation
0.26
+63.06%
0.16
-52.99%
0.33
+11.33%
0.30
Current Capital Lease Obligation
0.26
+63.06%
0.16
-52.99%
0.33
+11.33%
0.30
Other Current Liabilities
0.06
-33.71%
0.09
-35.51%
0.14
—
Total Non Current Liabilities Net Minority Interest
0.28
-24.00%
0.38
+913.51%
0.04
-79.44%
0.18
Long Term Debt And Capital Lease Obligation
0.28
-24.00%
0.38
+2400.00%
0.01
-91.67%
0.18
Long Term Capital Lease Obligation
0.28
-24.00%
0.38
+2400.00%
0.01
-91.67%
0.18
Other Non Current Liabilities
—
—
0.02
—
Stockholders Equity
160.47
-24.26%
211.88
+96.92%
107.60
-16.41%
128.72
Common Stock Equity
160.47
-24.26%
211.88
+96.92%
107.60
-16.41%
128.72
Capital Stock
0.01
-28.57%
0.01
+133.33%
0.00
+0.00%
0.00
Common Stock
0.01
-28.57%
0.01
+133.33%
0.00
+0.00%
0.00
Preferred Stock
—
—
—
—
Share Issued
47.77
-28.98%
67.26
+142.80%
27.70
+4.26%
26.57
Ordinary Shares Number
47.77
-28.98%
67.26
+142.80%
27.70
+4.26%
26.57
Additional Paid In Capital
449.76
+1.82%
441.73
+67.59%
263.58
+5.46%
249.93
Retained Earnings
-289.73
-26.04%
-229.88
-47.38%
-155.98
-29.06%
-120.86
Gains Losses Not Affecting Retained Earnings
0.43
+1791.30%
0.02
+1250.00%
-0.00
+99.44%
-0.36
Other Equity Adjustments
0.43
+1791.30%
0.02
+1250.00%
-0.00
+99.44%
-0.36
Total Equity Gross Minority Interest
160.47
-24.26%
211.88
+96.92%
107.60
-16.41%
128.72
Total Capitalization
160.47
-24.26%
211.88
+96.92%
107.60
-16.41%
128.72
Working Capital
98.86
-34.06%
149.94
+39.58%
107.42
-16.27%
128.30
Invested Capital
160.47
-24.26%
211.88
+96.92%
107.60
-16.41%
128.72
Total Debt
0.54
+1.69%
0.53
+52.44%
0.35
-27.29%
0.48
Capital Lease Obligations
0.54
+1.69%
0.53
+52.44%
0.35
-27.29%
0.48
Net Tangible Assets
160.47
-24.26%
211.88
+96.92%
107.60
-16.41%
128.72
Tangible Book Value
160.47
-24.26%
211.88
+96.92%
107.60
-16.41%
128.72
Available For Sale Securities
59.57
-3.31%
61.61
—
—
Dueto Related Parties Current
—
—
—
—
Investmentin Financial Assets
59.57
-3.31%
61.61
0.00
0.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-54.36
-249.29%
-15.56
+24.45%
-20.60
+44.88%
-37.37
Cash Flow From Continuing Operating Activities
-54.36
-249.29%
-15.56
+24.45%
-20.60
+44.88%
-37.37
Net Income From Continuing Operations
-59.85
+19.01%
-73.90
-110.42%
-35.12
+22.38%
-45.24
Depreciation Amortization Depletion
0.10
0.00
—
—
Depreciation And Amortization
0.10
0.00
—
—
Other Non Cash Items
0.20
-99.61%
51.88
+12709.63%
0.41
-8.58%
0.44
Stock Based Compensation
8.05
+44.93%
5.56
-56.61%
12.81
+83.18%
6.99
Asset Impairment Charge
—
0.00
-100.00%
0.18
0.00
Operating Gains Losses
0.02
+142.86%
-0.04
+86.18%
-0.30
-174.51%
0.41
Net Foreign Currency Exchange Gain Loss
0.02
+142.86%
-0.04
+86.18%
-0.30
-174.51%
0.41
Change In Working Capital
-0.60
-135.39%
1.70
-54.89%
3.76
+1692.38%
0.21
Change In Prepaid Assets
-0.82
-142.02%
1.94
-73.65%
7.37
+679.89%
0.94
Change In Payables And Accrued Expense
1.94
+534.75%
0.30
+109.25%
-3.30
-1346.93%
-0.23
Change In Accrued Expense
0.37
-74.26%
1.45
+155.30%
-2.61
-714.82%
0.42
Change In Payable
1.56
+237.19%
-1.14
-66.18%
-0.69
-5.05%
-0.65
Change In Account Payable
1.56
+237.19%
-1.14
-66.18%
-0.69
-5.05%
-0.65
Change In Other Current Assets
-1.51
-657.00%
-0.20
-273.91%
0.12
+291.67%
-0.06
Change In Other Current Liabilities
-0.21
+40.69%
-0.35
+17.30%
-0.42
+5.59%
-0.45
Investing Cash Flow
2.83
+102.34%
-121.09
-275.54%
68.98
+100.29%
34.44
Cash Flow From Continuing Investing Activities
2.83
+102.34%
-121.09
-275.54%
68.98
+100.29%
34.44
Net PPE Purchase And Sale
-0.19
0.00
—
—
Purchase Of PPE
-0.19
0.00
—
—
Capital Expenditure
-0.19
—
—
—
Net Investment Purchase And Sale
3.02
+102.71%
-111.45
-261.56%
68.98
+100.29%
34.44
Purchase Of Investment
-108.08
+18.24%
-132.20
-126.17%
-58.45
+33.55%
-87.96
Sale Of Investment
111.10
+435.41%
20.75
-83.72%
127.43
+4.11%
122.40
Net Other Investing Changes
—
-9.64
—
—
Financing Cash Flow
-0.02
-100.02%
130.73
+15444.47%
0.84
0.00
Cash Flow From Continuing Financing Activities
-0.02
-100.02%
130.73
+15444.47%
0.84
0.00
Net Common Stock Issuance
0.00
-100.00%
119.75
0.00
0.00
Proceeds From Stock Option Exercised
0.07
-99.41%
10.98
+1205.47%
0.84
0.00
Net Other Financing Charges
-0.09
—
—
—
Changes In Cash
-51.54
-769.94%
-5.92
-112.04%
49.22
+1780.54%
-2.93
Effect Of Exchange Rate Changes
0.00
-100.00%
0.04
-86.18%
0.30
+174.51%
-0.41
Beginning Cash Position
87.23
-6.32%
93.11
+113.63%
43.59
-7.11%
46.92
End Cash Position
35.69
-59.09%
87.23
-6.32%
93.11
+113.63%
43.59
Free Cash Flow
-54.54
-250.48%
-15.56
+24.45%
-20.60
+44.88%
-37.37
Amortization Of Securities
-2.27
-200.40%
-0.76
+67.52%
-2.33
-1216.95%
-0.18
Common Stock Issuance
0.00
-100.00%
119.75
0.00
0.00
Issuance Of Capital Stock
0.00
-100.00%
119.75
0.00
0.00
Net Preferred Stock Issuance
—
—
—
0.00
Preferred Stock Issuance
—
—
—
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category